C-F8NGBiotein
saliva assay, protein biomarkers, cellular damage
diagnostics
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-F8NG
C-F8NGC-F8NGsaliva assay, protein biomarkers, cellular damage
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Biotein presents the belief that aging can be treated, or potentially cured, by studying senescent cells and identifying distinguishing biomarkers in their mitochondria. The company describes a process of collecting fluorescence microscopy images of senescent, live, and dead cells, using a convolutional neural network to detect key cellular markers, and then using those markers to develop targeted therapies, implying that senescent-cell biology is a tractable route toward longevity interventions.
SourceBiotein presents itself as a longevity research company focused on "ending aging" and improving the future of health. It states that senescent cells are harmful inflammatory cells that accumulate in the body, drive aging and aging-related disease, and that measuring their levels through an accessible blood test can help people track biological age and age more gracefully.
SourceBiotein presents itself as a team working toward a cure for aging and related diseases, with the stated belief that aging can be addressed through measurable biological mechanisms. The snapshot suggests the company views cellular senescence, mitochondrial changes, epigenetic markers, and declining ATP production from loss of proton motive force as tractable drivers of aging that can be analyzed and potentially corrected, while also applying similar experimental approaches to genetic disease.
SourceBiotein states that age-related disease risk can be understood and reduced by measuring molecular signs of cellular damage before disease appears. The company presents aging as a process in which cells undergo harmful changes that damage mitochondria, telomeres, and proteins, increasing the risk of neurodegenerative and cardiovascular diseases, and argues that a low-cost saliva test can quantify this damage, estimate disease risk, and guide lifestyle interventions early enough to improve outcomes.
Source